Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app detect postpartum depression? new study aims to find out

NCT ID NCT06364488

Knowledge-focused Sponsor: BlueSkeye AI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a mobile app called TrueBlue that automatically measures mood in pregnant women and new mothers. Researchers want to see if the app is safe, easy to use, and agrees with standard depression questionnaires. About 125 participants in Nottinghamshire, UK, will use the app for 12 weeks while their mood is tracked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TrueBlue mobile phone app
What this could lead to
If successful, this app could provide a simple, automated way to monitor mood changes and catch early signs of depression or anxiety in new and expecting mothers.
What could go wrong
This is a small, early-stage feasibility study, not a treatment trial. The app may not accurately detect mood changes, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 125 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- 18 years or older * Fluent in spoken and written English * Has capacity to provide consent * At least 12 weeks pregnant or less than 12 weeks postpartum * Access to internet connectivity * Access to a compatible smart phone device (for up to 10 participants, where needed through not having a personal device, this access may be provided through the study team). * Has a current GP within Nottinghamshire Exclusion Criteria: * ● Current clinically diagnosed psychiatric disorder other than depression * Previous history of a clinically diagnosed psychiatric disorder, other than depression and generalised anxiety disorder (including previous Psychosis, Bipolar Disorder, Personality Disorder, Substance Abuse Disorders, Eating Disorders) * Clinical diagnosis of an Autistic Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Parkinson's Disease or other current Neurological Disorder.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anhedonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Anhedonia anxiety anxiety disorder Depression depressive disorder perinatal asphyxia postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anhedonia Anxiety Anxiety in pregnancy Depression Depression, postpartum Perinatal depression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nottingham University Hospitals NHS Trust

    NOT_YET_RECRUITING

    Nottingham, Nottinghamshire, NG7 2UH, United Kingdom

  • Nottinghamshire Healthcare NHS Foundation Trust

    RECRUITING

    Nottingham, NG3 6AA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.